Literature DB >> 24144615

A cluster analysis of tic symptoms in children and adults with Tourette syndrome: clinical correlates and treatment outcome.

Joseph F McGuire1, Epiphanie Nyirabahizi, Katharina Kircanski, John Piacentini, Alan L Peterson, Douglas W Woods, Sabine Wilhelm, John T Walkup, Lawrence Scahill.   

Abstract

Cluster analytic methods have examined the symptom presentation of chronic tic disorders (CTDs), with limited agreement across studies. The present study investigated patterns, clinical correlates, and treatment outcome of tic symptoms. 239 youth and adults with CTDs completed a battery of assessments at baseline to determine diagnoses, tic severity, and clinical characteristics. Participants were randomly assigned to receive either a comprehensive behavioral intervention for tics (CBIT) or psychoeducation and supportive therapy (PST). A cluster analysis was conducted on the baseline Yale Global Tic Severity Scale (YGTSS) symptom checklist to identify the constellations of tic symptoms. Four tic clusters were identified: Impulse Control and Complex Phonic Tics; Complex Motor Tics; Simple Head Motor/Vocal Tics; and Primarily Simple Motor Tics. Frequencies of tic symptoms showed few differences across youth and adults. Tic clusters had small associations with clinical characteristics and showed no associations to the presence of coexisting psychiatric conditions. Cluster membership scores did not predict treatment response to CBIT or tic severity reductions. Tic symptoms distinctly cluster with little difference across youth and adults, or coexisting conditions. This study, which is the first to examine tic clusters and response to treatment, suggested that tic symptom profiles respond equally well to CBIT. Clinical trials.gov. identifiers: NCT00218777; NCT00231985.
© 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chronic tic disorders; Cluster analysis; Comprehensive behavioral intervention for tics; Habit reversal training; Tic symptom profiles; Treatment outcome

Mesh:

Year:  2013        PMID: 24144615      PMCID: PMC3941714          DOI: 10.1016/j.psychres.2013.09.021

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  30 in total

Review 1.  Tic disorders: some key issues for DSM-V.

Authors:  John T Walkup; Ygor Ferrão; James F Leckman; Dan J Stein; Harvey Singer
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

2.  Test-retest reliability of anxiety symptoms and diagnoses with the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions.

Authors:  W K Silverman; L M Saavedra; A A Pina
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-08       Impact factor: 8.829

3.  Coprophenomena in Tourette syndrome.

Authors:  Roger D Freeman; Samuel H Zinner; Kirsten R Müller-Vahl; Diane K Fast; Larry J Burd; Yukiko Kano; Aribert Rothenberger; Veit Roessner; Jacob Kerbeshian; Jeremy S Stern; Joseph Jankovic; Thomas Loughin; Piotr Janik; Gary Shady; Mary M Robertson; Anthony E Lang; Cathy Budman; Alida Magor; Ruth Bruun; Cheston M Berlin
Journal:  Dev Med Child Neurol       Date:  2008-12-04       Impact factor: 5.449

4.  Concurrent validity of the anxiety disorders section of the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions.

Authors:  Jeffrey J Wood; John C Piacentini; R Lindsey Bergman; James McCracken; Velma Barrios
Journal:  J Clin Child Adolesc Psychol       Date:  2002-09

5.  The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 2: tentative explanations for differing prevalence figures in GTS, including the possible effects of psychopathology, aetiology, cultural differences, and differing phenotypes.

Authors:  Mary M Robertson
Journal:  J Psychosom Res       Date:  2008-10-02       Impact factor: 3.006

Review 6.  Clinical course of Tourette syndrome.

Authors:  Michael H Bloch; James F Leckman
Journal:  J Psychosom Res       Date:  2009-12       Impact factor: 3.006

7.  A measure of functional impairment in youth with Tourette's syndrome.

Authors:  Eric A Storch; Caleb W Lack; Laura E Simons; Wayne K Goodman; Tanya K Murphy; Gary R Geffken
Journal:  J Pediatr Psychol       Date:  2007-05-23

8.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

Authors:  W K Goodman; L H Price; S A Rasmussen; C Mazure; R L Fleischmann; C L Hill; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1989-11

9.  The Gilles de la Tourette syndrome: a principal component factor analytic study of a large pedigree.

Authors:  Mary M Robertson; Andrea E Cavanna
Journal:  Psychiatr Genet       Date:  2007-06       Impact factor: 2.458

10.  Cluster analysis of the Yale Global Tic Severity Scale (YGTSS): symptom dimensions and clinical correlates in an outpatient youth sample.

Authors:  Katharina Kircanski; Douglas W Woods; Susanna W Chang; Emily J Ricketts; John C Piacentini
Journal:  J Abnorm Child Psychol       Date:  2010-08
View more
  17 in total

1.  A multicenter examination and strategic revisions of the Yale Global Tic Severity Scale.

Authors:  Joseph F McGuire; John Piacentini; Eric A Storch; Tanya K Murphy; Emily J Ricketts; Douglas W Woods; John W Walkup; Alan L Peterson; Sabine Wilhelm; Adam B Lewin; James T McCracken; James F Leckman; Lawrence Scahill
Journal:  Neurology       Date:  2018-04-13       Impact factor: 9.910

2.  Characterization of the pediatric acute-onset neuropsychiatric syndrome phenotype.

Authors:  Tanya K Murphy; Priyal D Patel; Joseph F McGuire; Allison Kennel; P Jane Mutch; E Carla Parker-Athill; Camille E Hanks; Adam B Lewin; Eric A Storch; Megan D Toufexis; Gul H Dadlani; Carina A Rodriguez
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-10-14       Impact factor: 2.576

3.  Effect of behavior therapy for Tourette's disorder on psychiatric symptoms and functioning in adults.

Authors:  Joseph F McGuire; Emily J Ricketts; Lawrence Scahill; Sabine Wilhelm; Douglas W Woods; John Piacentini; John T Walkup; Alan L Peterson
Journal:  Psychol Med       Date:  2019-08-27       Impact factor: 7.723

4.  Investigating Acupoint Selection and Combinations of Acupuncture for Tic Disorders: An Association Rule Mining and Network Analysis Study.

Authors:  Jieting Chen; Yufeng Xie; Qingchan Lin; Ziliang Qian; Jun Feng; Jianmei Zhang; Yun Chen; Wenhan Chen; Yueting Wu; Ziyi Guo
Journal:  Front Neurol       Date:  2022-06-10       Impact factor: 4.086

Review 5.  The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.

Authors:  Cathy L Budman
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

6.  Behavior Therapy for Tic Disorders: An Evidenced-based Review and New Directions for Treatment Research.

Authors:  Joseph F McGuire; Emily J Ricketts; John Piacentini; Tanya K Murphy; Eric A Storch; Adam B Lewin
Journal:  Curr Dev Disord Rep       Date:  2015-09-14

7.  An Empirical Examination of Symptom Substitution Associated With Behavior Therapy for Tourette's Disorder.

Authors:  Alan L Peterson; Joseph F McGuire; Sabine Wilhelm; John Piacentini; Douglas W Woods; John T Walkup; John P Hatch; Robert Villarreal; Lawrence Scahill
Journal:  Behav Ther       Date:  2015-09-11

Review 8.  The Semiology of Tics, Tourette's, and Their Associations.

Authors:  Christos Ganos; Alexander Münchau; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2014-06-10

9.  Moderators and predictors of response to behavior therapy for tics in Tourette syndrome.

Authors:  Denis G Sukhodolsky; Douglas W Woods; John Piacentini; Sabine Wilhelm; Alan L Peterson; Lily Katsovich; James Dziura; John T Walkup; Lawrence Scahill
Journal:  Neurology       Date:  2017-02-15       Impact factor: 9.910

10.  Bothersome tics in patients with chronic tic disorders: Characteristics and individualized treatment response to behavior therapy.

Authors:  Joseph F McGuire; John Piacentini; Lawrence Scahill; Douglas W Woods; Robert Villarreal; Sabine Wilhelm; John T Walkup; Alan L Peterson
Journal:  Behav Res Ther       Date:  2015-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.